Oncocytic carcinoma of the parotid gland with late cervical lymph
Cervical Carcinoma Presentation (PATH 752)
-
Upload
l-luketic -
Category
Health & Medicine
-
view
2.438 -
download
2
description
Transcript of Cervical Carcinoma Presentation (PATH 752)
![Page 1: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/1.jpg)
Presented By: L. Luketic
![Page 2: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/2.jpg)
Definitions: Cervical Dysplasia: is abnormal cell growth
on the surface lining of the cervix, which may progress to cervical cancer
Cervical Cancer: cancer that arises in the tissues of the uterine cervix
Pap (Papanicolaou) Smear/Test: is a cytologic exfoliative screening test
Intraepithelial: is the layer of cells that forms the surface of the cervix
![Page 3: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/3.jpg)
Definitions Continued: Koilocytic atypia: are nuclear alterations and is a
cytoplasmic perinuclear halo
Microinvasive Carcinoma: stromal invasion of the cervical epithelium does not extend deeper than 3mm and is not wider than 7mm
Carcinoma in situ: a group of abnormal cells that have not spread, but may progress to invasive cancer
Colposcopy: a procedure that uses a lighted magnifying tool (colposcope), allowing the doctor to take a closer look at the cervix and vagina
![Page 4: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/4.jpg)
Cervical SCJ & T zone: Squamocolumnar Junction (SCJ):
Non-keratinized stratified Squamous epithelium (ectocervix) Non-ciliated simple columnar epithelium (endocervix)
Transformation Zone (T zone):Original SCJ New SCJ
Clinical significance of the SCJ:Almost ALL primary cervical carcinomas arise
in this region of the cervix
![Page 5: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/5.jpg)
Cervical Squamocolumar Junction: (Robbins Fig. 22-16)
![Page 6: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/6.jpg)
Cervical SCJ & T zone Grossly:
Merck & Co., Inc. Human Papillomavirus, Monographs in Medicine. Whitehouse Station, NJ: Merck and Co; 2008.
![Page 7: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/7.jpg)
SCJ & T zone Histologically:
http://1.bp.blogspot.com/_OwoEg7Db_AE/TQTYcJz2cTI/AAAAAAAAA9o/Q5neoLm6-CQ/s1600/CTZ%2Bb.png
![Page 8: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/8.jpg)
Incidence & Mortality Rate of Cervical Carcinomas: According to the National Cancer
Institute, estimated new cases and deaths from cervical (uterine cervix) cancer in the U.S. in 2013 are:New cases: 12,340Deaths: 4,030
Worldwide, cervical carcinoma is the second most common cancer in women
![Page 9: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/9.jpg)
Pathogenesis of Cervical Neoplasia: Most HPV infections are eliminated by our
immune system
HPV infects immature squamous epithelial cells
HPV replicates in maturing squamous cells koilocytic atypia
HPV activates the cell cycle by interfering with the function of Rb and p53
![Page 10: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/10.jpg)
Pathogenesis of Cervical Neoplasia Continued: E6 HPV oncoprotein binds to p53 interrupted
apoptosis of genetically altered cell
E7 HPV oncoprotein binds to RB promotes cell growth and up regulation of cyclin E (E7)
Together E6 & E7 induce centrosome duplication and genomic instability
Factors other than HPV also play a role in cervical carcinoma
![Page 11: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/11.jpg)
http://www.nature.com/nrc/journal/v7/n1/fig_tab/nrc2050_F1.html
![Page 12: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/12.jpg)
Roden and Wu Nature Reviews Cancer 6, 753–763 (October 2006) | doi:10.1038/nrc1973
![Page 13: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/13.jpg)
Risk Factors for Cervical Cancer: Persistent infection with a high oncogenic
risk HPV, e.g., HPV 16 or HPV 18 Multiple sexual partners A male partner with multiple previous or
current sexual partners Young age at first intercourse High parity Immunosuppression Age Use of oral contraceptives Use of nicotine/smoking
![Page 14: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/14.jpg)
Human Papillomavirus (HPV): “HPV is the most common viral STI in the U.S.”
Harald zur Hausen: discovered that HPV is a major cause of cervical carcinoma
2 Classifications of HPV Infection:Low oncogenic risk HPVs: (6, 11, …)High oncogenic risk HPVs: (16, 18, 31, 33, …)
The most significant factor in cervical oncogenesis is said to be “High Oncogenic risk HPVs”
![Page 15: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/15.jpg)
ROBBINS TABLE 22-1
![Page 16: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/16.jpg)
Cervical Intraepithelial Neoplasia (CIN): Precursor to Cervical SCC
Neoplastic changes of the ectocervical squamous epithelium
CIN I: caused by low oncogenic risk HPVsMild koilocytic atypia
CIN II: caused by high oncogenic risk HPVsModerate koilocytic atypia of the squamous cells
CIN III: caused by high oncogenic risk HPVsSevere koilocytic atypia of immature squamous cells
![Page 17: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/17.jpg)
Cervical Cancer Histology: Robbins Fig. 22-17Normal CIN I CIN II CIN III
![Page 18: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/18.jpg)
The cytology of a CIN seen on a Pap smear (Robbins Fig. 22-21)
![Page 19: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/19.jpg)
The Bethesda System: (LSIL) Low-grade Intraepithelial Lesions (LSIL):
Mild dysplasia
Do NOT directly progress to invasive carcinoma
HPV 6 & 11 cause ~90% of all condylomata acuminata
Koilocytic atypia of immature squamous cells = remains in the lower 1/3rd of epithelium
![Page 20: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/20.jpg)
The Bethesda System: (HSIL) High-grade Intraepithelial Lesions (HSIL):
Moderate to severe dysplasia
Pre-cancerous lesions
HPV types 16 & 18 have the highest correlation of causing cervical cancer○ HPV types 31 & 33 also have a high correlation of
causing cervical cancer
Koilocytic atypia of immature squamous cells = extends to 2/3rds of epithelial thickness
![Page 21: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/21.jpg)
HPV Groups/Types:
Expert Rev Mol Diagn. 2008;8(4):405-415. © 2008 Expert Reviews Ltd. http://www.medscape.com/viewarticle/585223
![Page 22: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/22.jpg)
Cervical Cancer Histology: (Robbins Fig. 22-18) LSIL – stained with multiple techniques
Ki-67 & p16 are used to confirm SIL diagnosis
![Page 23: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/23.jpg)
![Page 24: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/24.jpg)
ROBBINS TABLE 22-2
![Page 25: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/25.jpg)
Normal Cervix (Gross):
http://library.med.utah.edu/WebPath/jpeg4/FEM002.jpg
![Page 26: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/26.jpg)
Invasive Carcinoma of the Cervix Tumor extension is by direct MET,
involving adjacent tissues which can include:Paracervical tissuesUrinary bladderUretersRectumVagina
Local and distant lymph node METs Distant METs (liver, lungs, bone marrow,
other)
![Page 27: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/27.jpg)
4 Main Types of Primary Cervical Cancer: Squamous cell carcinoma (SCC) = most
common
Adenocarcinoma = 2nd most common
Adenosquamous carcinoma (or Mixed Cell Carcinomas)
Neuroendocrine (oat cell) carcinoma (NEC)
![Page 28: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/28.jpg)
SCC of the Uterine Cervix: SCCs most often arise at the SCJ Grossly: (3 forms)
Fungating (exophytic) or infiltrativeUlceratedInvasive lesion that causes induration or other
deformities of the cervix Histologically:
Nests and tongues of malignant cellsKeratinizing or Non-keratinizing
Clinical Symptoms:Early-stage: may be asymptomaticLater-stage: abnormal vaginal bleeding, increased
vaginal discharge, pelvic pain, or pain during intercourse
![Page 29: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/29.jpg)
Gross Cervical SCC: (Stage 1)
http://library.med.utah.edu/WebPath/FEMHTML/FEMIDX.html#2
![Page 30: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/30.jpg)
Cervical SCC (Gross) Extensive:
http://library.med.utah.edu/WebPath/FEMHTML/FEMIDX.html
![Page 31: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/31.jpg)
SCC of the Cervix (Robbins Fig. 22-19)
![Page 32: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/32.jpg)
Cervical Adenocarcinomas: Arise in the columnar epithelium (glandular cells that
produce mucus) of the endocervix Grossly:
Fungating (exophytic)InfiltrativeAbnormal mass/growth visible during colposcopy
Histologically: Glandular epithelium proliferation of malignant endocervical
cellsLarge hyperchromatic nucleiCytoplasm is mostly depleted of mucin
Clinical Symptoms: Abnormal vaginal bleeding/discharge, pelvic pain, or
asymptomatic
![Page 33: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/33.jpg)
Cervical Adenocarcinoma (Gross):
http://www.askjpc.org/wsco/wsc_showconference.php?id=294
![Page 34: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/34.jpg)
Adenocarcinoma of the Cervix (Robbins Fig. 22-20)
![Page 35: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/35.jpg)
Staging of Cervical Carcinoma (Robbins)
http://www.studentconsult.com/content/default.cfm?ISBN=9781416031215
![Page 36: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/36.jpg)
Prognosis:
5-year survival rates:Stage Ia = ~95%Stage Ib = ~80-90%Stage II = ~75%Stage III+ = <50%
Stage IV most common cause of death is local extension
The prognosis of adenosquamous and neuroendocrine carcinomas are worse than adenocarcinomas and SCCs
![Page 37: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/37.jpg)
Cervical Screening: Pap smears are the most efficient way to
test for/diagnose pre-invasive and invasive cervical carcinomasStudies show that there is an ~80% decrease in
cervical cancer (incidence & mortality rate) for women that get regular Pap smears○ Cervical SCC vs. Adenocarcinoma Pap smear accuracy
HPV DNA Testing: Similar to the Pap test, HPV DNA testing uses
cervical cells for lab testingDetermines positive/negative infection for HPV
strands most likely to cause cervical carcinoma Sensitivity vs. Specificity
![Page 38: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/38.jpg)
Prevention: Vaccines: Gardasil and Cervarix
Cervarix protects against HPV 16 & 18 (High oncogenic risk HPVs ~70%)
Gardasil protects against HPV 16 & 18 (High oncogenic risk HPVs ~70%) and HPV 6 & 11 (Low oncogenic risk HPVs ~90%)
Avoid smoking Remain abstinent Delay first intercourse Use a condom during intercourse Have fewer sexual partners
![Page 39: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/39.jpg)
Treatment Options:
Pre-malignant Lesions:Surgical ConizationCryosurgeryLaser surgeryLEEP (Loop Electrosurgical Excision Procedure)
Malignant Lesions:Surgery (i.e., hysterectomy/TAHBSO)Radiation TherapyChemotherapy
![Page 40: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/40.jpg)
Review
![Page 41: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/41.jpg)
Question # 1:
What is KOILOCYTIC ATYPIA?
![Page 42: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/42.jpg)
Answer to Question #1
Nuclear alterations and a cytoplasmic perinuclear halo
Commonly seen in dysplastic cells infected with HPV
![Page 43: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/43.jpg)
Question #2:
What region of the cervix do almost ALL cervical carcinomas arise?
![Page 44: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/44.jpg)
Answer to Question #2
Squamocolumnar Junction (SCJ)
![Page 45: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/45.jpg)
Question #3: Worldwide, how does cervical carcinoma
rank compared to other cancers in women?
![Page 46: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/46.jpg)
Answer to Question #3
2nd most common
![Page 47: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/47.jpg)
Question #4:
What is said to be the MOST significant risk factor in cervical oncogenesis?
![Page 48: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/48.jpg)
Answer to Question #4
High oncogenic risk HPV infections
![Page 49: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/49.jpg)
Question # 5:
What does CIN stand for, what are the subtypes, and what is the clinical significance?
![Page 50: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/50.jpg)
Answer to Question #5
Cervical Intraepithelial Neoplasia (CIN)I: Mild dysplasiaII: Moderate dysplasiaIII: Severe dysplasiaIII: Carcinoma in situ
Precursor to cervical cancer
![Page 51: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/51.jpg)
Question # 6:
What do LSIL and HSIL stand for and which main virus strands cause them?
![Page 52: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/52.jpg)
Answer to Question #6
Low-grade Squamous Intraepithelial LesionHPV 6 & 11
High-grade Squamous Intraepithelial LesionHPV 16 & 18
![Page 53: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/53.jpg)
Question # 7:
What are the 4 main types of primary cervical carcinoma (most common least common)?
![Page 54: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/54.jpg)
Answer to Question #7
Squamous Cell Carcinoma Adenocarcinoma Adenosquamous Carcinoma Neuroendocrine Carcinoma
![Page 55: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/55.jpg)
Question # 8:
What is the most efficient way to test for/diagnose pre-invasive/invasive cervical carcinoma?
![Page 56: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/56.jpg)
Answer to Question #8
Pap smear
![Page 57: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/57.jpg)
Question # 9:
What is the percent of decrease in incidence and mortality rate, in women that get regular Pap smears?
![Page 58: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/58.jpg)
Answer to Question #9
~80% decrease in cervical cancer (incidence & mortality rate) for women that get regular Pap smears
![Page 59: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/59.jpg)
Question # 10:
What are the 2 vaccines that prevent HPV, and what are the main strands they prevent?
![Page 60: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/60.jpg)
Answer to Question #10
Cervarix protects against:HPV 16 & 18 (High oncogenic risk HPVs
~70%)
Gardasil protects against: HPV 16 & 18 (High oncogenic risk HPVs
~70%)HPV 6 & 11 (Low oncogenic risk HPVs
~90%)
![Page 61: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/61.jpg)
References: Agnes Kathrine Lie, MD, PhD, Gunnar Kristensen, MD, PhD. Human Papillomavirus
E6/E7 mRNA Testing as a Predictive Marker for Cervical Carcinoma. Expert Rev Mol Diagn. 2008;8(4):405-415. Accessed <07/06/2013>.
"Cervical Cancer." American Cancer Society. American Cancer Society, 11 Apr. 2013. Web. 6 July 2013. <http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-what-is-cervical-cancer?sitearea=cri>.
Ciaran B. J. Woodman, Stuart I. Collins & Lawrence S. Young. The natural history of cervical HPV infection: unresolved issues. Nature Reviews Cancer 7, 11-
22 (January 2007). doi:10.1038/nrc2050
Damjanov, Ivan. Pathology Secrets. 3rd ed. Philadelphia: Saunders Elsevier, 2009. 342-44. Print.
Expert Rev Mol Diagn. 2008;8(4):405-415. © 2008 Expert Reviews Ltd. http://www.medscape.com/viewarticle/585223
http://screening.iarc.fr/atlasglossdef.php
http://www.askjpc.org/wsco/wsc_showconference.php?id=294
![Page 62: Cervical Carcinoma Presentation (PATH 752)](https://reader031.fdocuments.net/reader031/viewer/2022012400/5491f36fb47959c92b8b466d/html5/thumbnails/62.jpg)
References Continued: http://www.cap.org
http://www.mayoclinic.com/print/cervical-cancer/DS00167/DSECTION=all&METHOD=print
http://www.prn.org/index.php/coinfections/articleanogenital_hpv_neoplasia_hiv_positive_502
Kumar, Vinay, Abul Abbas, Nelson Fausto, and Jon Aster. Robbins and Cotran: Pathologic Basis of Disease. 8th ed. Philadelphia: Saunders Elsevier, 2010. 1017-24. Print.
National Cancer Institute: PDQ® Cervical Cancer Treatment. Bethesda, MD: National Cancer Institute. Date last modified <05/15/2013>. Available at: http://cancer.gov/cancertopics/pdq/treatment/cervical/HealthProfessional. Accessed <07/06/2013>.
Richard Roden & T.-C. Wu. How will HPV vaccines affect cervical cancer? Nature Reviews Cancer. 6, 753-763 (October 2006). doi:10.1038/nrc1973